Zymergen is part of the New Bioeconomy, helping unlock the power of biology to create essential chemicals and novel materials from clean, renewable sources. Through an unprecedented combination of robotic automation, software, data architecture and machine learning capabilities, Zymergen is making biology industrially relevant.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/16/15 | $44,000,000 | Series A |
AME Cloud Ventures Data Collective Draper Fisher Jurvetson ePlanet HVF Innovation Endeavors Obvious Ventures True Ventures Two Sigma Ventures | undisclosed |
| 10/11/16 | $130,000,000 | Series B |
AME Cloud Ventures Data Collective DFJ ICONIQ Capital Innovation Endeavors Obvious Ventures Prelude Ventures SoftBank Group Tao Capital Partners True Ventures Two Sigma Ventures | undisclosed |
| 12/13/18 | $400,000,000 | Series C |
DCVC DFJ Goldman Sachs Hanwha Asset Management Innovation Endeavors SoftBank Vision Fund  True Ventures Two Sigma Ventures | undisclosed |
